Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Fischer

Showing results (211-220 of 323) with videos related to

Pageof 33
Sort By:
Cancer Research|October 17, 2019
A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified NeuroblastomaLuca Montemurro, Salvatore Raieli, Silvia Angelucci, et al.
Oncotarget|April 11, 2015
MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastomaDiana T Lau, Claudia L Flemming, Samuele Gherardi, et al.
Human Molecular Genetics|August 9, 2014
p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomasDaniel Dreidax, Steffen Bannert, Kai-Oliver Henrich, et al.
Nature Reviews. Microbiology|May 29, 2026
Infection cycles of viruses of the phylum NucleocytoviricotaChantal Abergel, Jônatas Santos Abrahão, Fasseli Coulibaly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2018
LDHA in Neuroblastoma Is Associated with Poor Outcome and Its Depletion Decreases Neuroblastoma Growth Independent of Aerobic GlycolysisCarmen Dorneburg, Matthias Fischer, Thomas F E Barth, et al.
Current Alzheimer Research|October 26, 2013
Neuron-specific mitochondrial DNA deletion levels in sporadic Alzheimer's diseaseAnne Gerschütz, Helmut Heinsen, Edna Grünblatt, et al.
Oncotarget|August 18, 2016
Wnt signalling is a bi-directional vulnerability of cancer cellsDavid J Duffy, Aleksandar Krstic, Thomas Schwarzl, et al.
The Lancet. Oncology|November 15, 2021
Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion studyMatthias Fischer, Lucas Moreno, David S Ziegler, et al.
Journal of Alzheimer'S Disease : JAD|December 17, 2013
Neuron-specific alterations in signal transduction pathways associated with Alzheimer's diseaseAnne Gerschütz, Helmut Heinsen, Edna Grünblatt, et al.
Cancer Research|December 29, 2020
Subcellular Distribution of p53 by the p53-Responsive lncRNA <i>NBAT1</i> Determines Chemotherapeutic Response in NeuroblastomaSanhita Mitra, Somsundar Veppil Muralidharan, Mirco Di Marco, et al.
Pageof 33

Showing results (211-220 of 323) with videos related to

Sort By:
Pageof 33
Cancer Research|October 17, 2019
A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified NeuroblastomaLuca Montemurro, Salvatore Raieli, Silvia Angelucci, et al.
Oncotarget|April 11, 2015
MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastomaDiana T Lau, Claudia L Flemming, Samuele Gherardi, et al.
Human Molecular Genetics|August 9, 2014
p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomasDaniel Dreidax, Steffen Bannert, Kai-Oliver Henrich, et al.
Nature Reviews. Microbiology|May 29, 2026
Infection cycles of viruses of the phylum NucleocytoviricotaChantal Abergel, Jônatas Santos Abrahão, Fasseli Coulibaly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2018
LDHA in Neuroblastoma Is Associated with Poor Outcome and Its Depletion Decreases Neuroblastoma Growth Independent of Aerobic GlycolysisCarmen Dorneburg, Matthias Fischer, Thomas F E Barth, et al.
Current Alzheimer Research|October 26, 2013
Neuron-specific mitochondrial DNA deletion levels in sporadic Alzheimer's diseaseAnne Gerschütz, Helmut Heinsen, Edna Grünblatt, et al.
Oncotarget|August 18, 2016
Wnt signalling is a bi-directional vulnerability of cancer cellsDavid J Duffy, Aleksandar Krstic, Thomas Schwarzl, et al.
The Lancet. Oncology|November 15, 2021
Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion studyMatthias Fischer, Lucas Moreno, David S Ziegler, et al.
Journal of Alzheimer'S Disease : JAD|December 17, 2013
Neuron-specific alterations in signal transduction pathways associated with Alzheimer's diseaseAnne Gerschütz, Helmut Heinsen, Edna Grünblatt, et al.
Cancer Research|December 29, 2020
Subcellular Distribution of p53 by the p53-Responsive lncRNA <i>NBAT1</i> Determines Chemotherapeutic Response in NeuroblastomaSanhita Mitra, Somsundar Veppil Muralidharan, Mirco Di Marco, et al.
Pageof 33